Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progression
BackgroundQuality of life， as a major criterion for judging the clinical outcome of ovarian cancer patients， can be affected by adverse psychological symptoms of patients. Meanwhile， fear of disease progression， as a frequent psychological symptom among cancer survivors， is significantly influenced...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Sichuan Mental Health
2023-12-01
|
| Series: | Sichuan jingshen weisheng |
| Subjects: | |
| Online Access: | http://www.psychjm.net.cn/scjswszzen/ch/reader/view_abstract.aspx?file_no=202306010&flag=1 |
| _version_ | 1797356752249815040 |
|---|---|
| author | Sun Hongfang Chen Ling Zhang Jing Wang Yan Liu Hongshuang |
| author_facet | Sun Hongfang Chen Ling Zhang Jing Wang Yan Liu Hongshuang |
| author_sort | Sun Hongfang |
| collection | DOAJ |
| description | BackgroundQuality of life， as a major criterion for judging the clinical outcome of ovarian cancer patients， can be affected by adverse psychological symptoms of patients. Meanwhile， fear of disease progression， as a frequent psychological symptom among cancer survivors， is significantly influenced by metacognition， while there is a paucity of research into the specific correlation among the three in patients with ovarian cancer.ObjectiveTo explore the correlation among fear of disease progression， metacognition and quality of life in patients with ovarian cancer， and to test the role of fear of disease progression in the relationship between metacognition and quality of life， so as to provide references for improving the quality of life in patients with ovarian cancer.MethodsA total of 135 patients with ovarian cancer hospitalized in Cangzhou People's Hospital of Hebei Province from January 2019 to December 2022 were selected. All subjects were requested to complete the Functional Assessment of Cancer Therapy-Ovarian Cancer （FACT-O）， Fear of Progression Questionnaire-Short Form （FoP-Q-SF） and Metacognition Questionnaire （MCQ） to assess their quality of life， fear of disease progression and metacognitive level. Pearson correlation analysis was adopted to examine the correlation among the above scales. Process v3.5 macro program was utilized to determine the mediating effect of fear of disease progression on the relationship between metacognition and quality of life， and nonparametric Bootstrap with bias-correction was used to test the mediating effect.ResultsA total of 122 patients （90.37%） with ovarian cancer completed the effective questionnaire survey. Patients scored （90.52±17.13） on FACT-O， （68.52±16.31） on MCQ， and （37.72±8.91） on FoP-Q-SF. Pearson correlation analysis denoted that FoP-Q-SF score was negatively correlated with FACT-O score （r=-0.412， P<0.05） and positively correlated with MCQ score （r=0.241， P<0.05）， and MCQ score was negatively correlated with FACT-O score （r=-0.453， P<0.05）. Analysis demonstrated that the total effect of metacognition on quality of life was -0.298 （95% CI： -0.402~-0.186）. The direct effect of metacognition on quality of life was -0.219 （95% CI： -0.504~-0.277）， accounting for 73.49% of the total effect， and the indirect effect of metacognition on quality of life via fear of disease progression was -0.079 （95% CI： -0.162~-0.037）， accounting for 26.51% of the total effect.ConclusionQuality of life is reduced in patients with ovarian cancer， and fear of disease progression plays a partial mediating role in the relationship between metacognition and quality of life. |
| first_indexed | 2024-03-08T14:32:09Z |
| format | Article |
| id | doaj.art-801eed36c2a94d489f9f0cb4cc5f75f8 |
| institution | Directory Open Access Journal |
| issn | 1007-3256 |
| language | zho |
| last_indexed | 2024-03-08T14:32:09Z |
| publishDate | 2023-12-01 |
| publisher | Editorial Office of Sichuan Mental Health |
| record_format | Article |
| series | Sichuan jingshen weisheng |
| spelling | doaj.art-801eed36c2a94d489f9f0cb4cc5f75f82024-01-12T08:51:54ZzhoEditorial Office of Sichuan Mental HealthSichuan jingshen weisheng1007-32562023-12-0136653253710.11886/scjsws202302250011007-3256（2023）06-0532-06Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progressionSun Hongfang0Chen Ling1Zhang Jing2Wang Yan3Liu Hongshuang4Cangzhou People's Hospital， Cangzhou 061000， ChinaCangzhou Medical College， Cangzhou 061000， ChinaCangzhou Medical College， Cangzhou 061000， ChinaCangzhou Medical College， Cangzhou 061000， ChinaBotou Hospital， Cangzhou 062150， ChinaBackgroundQuality of life， as a major criterion for judging the clinical outcome of ovarian cancer patients， can be affected by adverse psychological symptoms of patients. Meanwhile， fear of disease progression， as a frequent psychological symptom among cancer survivors， is significantly influenced by metacognition， while there is a paucity of research into the specific correlation among the three in patients with ovarian cancer.ObjectiveTo explore the correlation among fear of disease progression， metacognition and quality of life in patients with ovarian cancer， and to test the role of fear of disease progression in the relationship between metacognition and quality of life， so as to provide references for improving the quality of life in patients with ovarian cancer.MethodsA total of 135 patients with ovarian cancer hospitalized in Cangzhou People's Hospital of Hebei Province from January 2019 to December 2022 were selected. All subjects were requested to complete the Functional Assessment of Cancer Therapy-Ovarian Cancer （FACT-O）， Fear of Progression Questionnaire-Short Form （FoP-Q-SF） and Metacognition Questionnaire （MCQ） to assess their quality of life， fear of disease progression and metacognitive level. Pearson correlation analysis was adopted to examine the correlation among the above scales. Process v3.5 macro program was utilized to determine the mediating effect of fear of disease progression on the relationship between metacognition and quality of life， and nonparametric Bootstrap with bias-correction was used to test the mediating effect.ResultsA total of 122 patients （90.37%） with ovarian cancer completed the effective questionnaire survey. Patients scored （90.52±17.13） on FACT-O， （68.52±16.31） on MCQ， and （37.72±8.91） on FoP-Q-SF. Pearson correlation analysis denoted that FoP-Q-SF score was negatively correlated with FACT-O score （r=-0.412， P<0.05） and positively correlated with MCQ score （r=0.241， P<0.05）， and MCQ score was negatively correlated with FACT-O score （r=-0.453， P<0.05）. Analysis demonstrated that the total effect of metacognition on quality of life was -0.298 （95% CI： -0.402~-0.186）. The direct effect of metacognition on quality of life was -0.219 （95% CI： -0.504~-0.277）， accounting for 73.49% of the total effect， and the indirect effect of metacognition on quality of life via fear of disease progression was -0.079 （95% CI： -0.162~-0.037）， accounting for 26.51% of the total effect.ConclusionQuality of life is reduced in patients with ovarian cancer， and fear of disease progression plays a partial mediating role in the relationship between metacognition and quality of life.http://www.psychjm.net.cn/scjswszzen/ch/reader/view_abstract.aspx?file_no=202306010&flag=1ovarian cancermetacognitionfear of disease progressionquality of lifemediating role |
| spellingShingle | Sun Hongfang Chen Ling Zhang Jing Wang Yan Liu Hongshuang Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progression Sichuan jingshen weisheng ovarian cancer metacognition fear of disease progression quality of life mediating role |
| title | Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progression |
| title_full | Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progression |
| title_fullStr | Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progression |
| title_full_unstemmed | Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progression |
| title_short | Metacognition in relation to quality of life in patients with ovarian cancer： mediating role of fear of disease progression |
| title_sort | metacognition in relation to quality of life in patients with ovarian cancer mediating role of fear of disease progression |
| topic | ovarian cancer metacognition fear of disease progression quality of life mediating role |
| url | http://www.psychjm.net.cn/scjswszzen/ch/reader/view_abstract.aspx?file_no=202306010&flag=1 |
| work_keys_str_mv | AT sunhongfang metacognitioninrelationtoqualityoflifeinpatientswithovariancancermediatingroleoffearofdiseaseprogression AT chenling metacognitioninrelationtoqualityoflifeinpatientswithovariancancermediatingroleoffearofdiseaseprogression AT zhangjing metacognitioninrelationtoqualityoflifeinpatientswithovariancancermediatingroleoffearofdiseaseprogression AT wangyan metacognitioninrelationtoqualityoflifeinpatientswithovariancancermediatingroleoffearofdiseaseprogression AT liuhongshuang metacognitioninrelationtoqualityoflifeinpatientswithovariancancermediatingroleoffearofdiseaseprogression |